Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to latest Research, the global market for Point-of-care Testing (POCT) for Substance Abuse should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Point-of-care Testing (POCT) for Substance Abuse market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Point-of-care Testing (POCT) for Substance Abuse market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Based on Colloidal Gold segment holds a share about % in 2023 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Point-of-care Testing (POCT) for Substance Abuse include Roche, Danaher, Abbott, Siemens, Beijing Hotgen Biotech, Hangzhou Biotest Biotech CO.,LTD, Assure Tech, Orient Gene and Thermo Fisher, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Point-of-care Testing (POCT) for Substance Abuse. Report Highlights:
(1) Global Point-of-care Testing (POCT) for Substance Abuse market size (sales volume & revenue), history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Point-of-care Testing (POCT) for Substance Abuse market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(3) China Point-of-care Testing (POCT) for Substance Abuse market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(4) Global Point-of-care Testing (POCT) for Substance Abuse segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Point-of-care Testing (POCT) for Substance Abuse segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Point-of-care Testing (POCT) for Substance Abuse, capacity, production and trends.
(7) Point-of-care Testing (POCT) for Substance Abuse industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Based on Colloidal Gold
Based on Fluorescence Immunochromatography
Market segment by application, can be divided into
Hospital
Diagnostic Center
Road Traffic Safety
Military
Others
Market segment by players, this report covers
Roche
Danaher
Abbott
Siemens
Beijing Hotgen Biotech
Hangzhou Biotest Biotech CO.,LTD
Assure Tech
Orient Gene
Thermo Fisher
Guangzhou Wondfo Biotech Co.,Ltd.
Hangzhou Alltest Biotech Co.,Ltd.
Beckman Coulter
Bio-Rad
BioMerieux
1 Market Overview
1.1 Point-of-care Testing (POCT) for Substance Abuse Definition
1.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Size and Forecast
1.2.1 By Revenue, Global Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019-2030
1.2.2 By Sales Volume, Global Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019-2030
1.2.3 Global Point-of-care Testing (POCT) for Substance Abuse Price Trend, 2019-2030
1.3 China Point-of-care Testing (POCT) for Substance Abuse Market Size and Forecast
1.3.1 By Revenue, China Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019-2030
1.3.2 By Sales Volume, China Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019-2030
1.3.3 China Point-of-care Testing (POCT) for Substance Abuse Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Point-of-care Testing (POCT) for Substance Abuse Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Point-of-care Testing (POCT) for Substance Abuse Share in Global Market, 2019-2030
1.4.3 Point-of-care Testing (POCT) for Substance Abuse Market Size: China VS Global, 2019-2030
1.5 Point-of-care Testing (POCT) for Substance Abuse Market Dynamics
1.5.1 Point-of-care Testing (POCT) for Substance Abuse Market Drivers
1.5.2 Point-of-care Testing (POCT) for Substance Abuse Market Restraints
1.5.3 Point-of-care Testing (POCT) for Substance Abuse Industry Trends
1.5.4 Point-of-care Testing (POCT) for Substance Abuse Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Company, 2019-2024
2.2 Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume by Company, 2019-2024
2.3 Global Point-of-care Testing (POCT) for Substance Abuse Price by Company, 2019-2024
2.4 Global Point-of-care Testing (POCT) for Substance Abuse Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Point-of-care Testing (POCT) for Substance Abuse Concentration Ratio
2.6 Global Point-of-care Testing (POCT) for Substance Abuse Mergers & Acquisitions, Expansion Plans
2.7 Global Point-of-care Testing (POCT) for Substance Abuse Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Point-of-care Testing (POCT) for Substance Abuse Revenue by Company, 2019-2024
3.2 China Point-of-care Testing (POCT) for Substance Abuse Sales Volume by Company, 2019-2024
3.3 China Point-of-care Testing (POCT) for Substance Abuse Point-of-care Testing (POCT) for Substance Abuse Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Point-of-care Testing (POCT) for Substance Abuse Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Point-of-care Testing (POCT) for Substance Abuse Domestic VS Export
3.6 China Market, Point-of-care Testing (POCT) for Substance Abuse Import & Export
3.6.1 China Market, Point-of-care Testing (POCT) for Substance Abuse Import & Export, 2019-2030
3.6.2 China Point-of-care Testing (POCT) for Substance Abuse Import & Export Trends
3.6.3 Main Sources of China Point-of-care Testing (POCT) for Substance Abuse Import
3.6.4 Export Destination of China Point-of-care Testing (POCT) for Substance Abuse
4 Point-of-care Testing (POCT) for Substance Abuse Production by Region
4.1 Global Point-of-care Testing (POCT) for Substance Abuse Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Point-of-care Testing (POCT) for Substance Abuse Manufacturers
4.3 Global Major Manufacturers, Point-of-care Testing (POCT) for Substance Abuse Capacity Expansion and Future Plans
4.4 Global Point-of-care Testing (POCT) for Substance Abuse Capacity by Region
4.5 Global Point-of-care Testing (POCT) for Substance Abuse Production by Region
4.5.1 Global Point-of-care Testing (POCT) for Substance Abuse Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Point-of-care Testing (POCT) for Substance Abuse Production by Region, 2019-2024
4.5.3 Global Point-of-care Testing (POCT) for Substance Abuse Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Point-of-care Testing (POCT) for Substance Abuse Industry Chain
5.2 Point-of-care Testing (POCT) for Substance Abuse Upstream Analysis
5.2.1 Point-of-care Testing (POCT) for Substance Abuse Core Raw Materials
5.2.2 Main Manufacturers of Point-of-care Testing (POCT) for Substance Abuse Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Point-of-care Testing (POCT) for Substance Abuse Production Mode
5.6 Point-of-care Testing (POCT) for Substance Abuse Procurement Model
5.7 Point-of-care Testing (POCT) for Substance Abuse Industry Sales Model and Sales Channels
5.7.1 Point-of-care Testing (POCT) for Substance Abuse Sales Model
5.7.2 Point-of-care Testing (POCT) for Substance Abuse Typical Distributors
6 Sights by Type
6.1 Point-of-care Testing (POCT) for Substance Abuse Classification
6.1.1 Based on Colloidal Gold
6.1.2 Based on Fluorescence Immunochromatography
6.2 By Type, Global Point-of-care Testing (POCT) for Substance Abuse Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Point-of-care Testing (POCT) for Substance Abuse Revenue, 2019-2030
6.4 By Type, Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030
6.5 By Type, Global Point-of-care Testing (POCT) for Substance Abuse Price, 2019-2030
7 Sights by Application
7.1 Point-of-care Testing (POCT) for Substance Abuse Segment by Application
7.1.1 Hospital
7.1.2 Diagnostic Center
7.1.3 Road Traffic Safety
7.1.4 Military
7.1.5 Others
7.2 By Application, Global Point-of-care Testing (POCT) for Substance Abuse Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Point-of-care Testing (POCT) for Substance Abuse Revenue, 2019-2030
7.4 By Application, Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030
7.5 By Application, Global Point-of-care Testing (POCT) for Substance Abuse Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Point-of-care Testing (POCT) for Substance Abuse Revenue, 2019-2030
8.3 By Region, Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Point-of-care Testing (POCT) for Substance Abuse Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share
8.5 Europe
8.5.1 Europe Point-of-care Testing (POCT) for Substance Abuse Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share
8.7 South America
8.7.1 South America Point-of-care Testing (POCT) for Substance Abuse Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Point-of-care Testing (POCT) for Substance Abuse Market Size & CAGR,2019 VS 2024 VS 2030
9.2 By Country, Global Point-of-care Testing (POCT) for Substance Abuse Revenue, 2019-2030
9.3 By Country, Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019-2030
9.4.2 By Company, U.S. Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023
9.4.3 By Type, U.S. Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.4.4 By Application, U.S. Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.5 Europe
9.5.1 Europe Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019-2030
9.5.2 By Company, Europe Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023
9.5.3 By Type, Europe Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.5.4 By Application, Europe Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.6 China
9.6.1 China Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019-2030
9.6.2 By Company, China Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023
9.6.3 By Type, China Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.6.4 By Application, China Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.7 Japan
9.7.1 Japan Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019-2030
9.7.2 By Company, Japan Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023
9.7.3 By Type, Japan Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.7.4 By Application, Japan Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.8 South Korea
9.8.1 South Korea Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019-2030
9.8.2 By Company, South Korea Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023
9.8.3 By Type, South Korea Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.8.4 By Application, South Korea Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023
9.9.3 By Type, Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.9.4 By Application, Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.10 India
9.10.1 India Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019-2030
9.10.2 By Company, India Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023
9.10.3 By Type, India Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.10.4 By Application, India Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023
9.11.3 By Type, Middle East & Asia Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
9.11.4 By Application, Middle East & Asia Point-of-care Testing (POCT) for Substance Abuse Market Size, Share, 2023 VS 2029
10 Manufacturers Profile
10.1 Roche
10.1.1 Roche Company Information, Head Office, Market Area and Industry Position
10.1.2 Roche Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.1.3 Roche Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Roche Company Profile and Main Business
10.1.5 Roche Recent Developments
10.2 Danaher
10.2.1 Danaher Company Information, Head Office, Market Area and Industry Position
10.2.2 Danaher Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.2.3 Danaher Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Danaher Company Profile and Main Business
10.2.5 Danaher Recent Developments
10.3 Abbott
10.3.1 Abbott Company Information, Head Office, Market Area and Industry Position
10.3.2 Abbott Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.3.3 Abbott Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Abbott Company Profile and Main Business
10.3.5 Abbott Recent Developments
10.4 Siemens
10.4.1 Siemens Company Information, Head Office, Market Area and Industry Position
10.4.2 Siemens Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.4.3 Siemens Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Siemens Company Profile and Main Business
10.4.5 Siemens Recent Developments
10.5 Beijing Hotgen Biotech
10.5.1 Beijing Hotgen Biotech Company Information, Head Office, Market Area and Industry Position
10.5.2 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.5.3 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Beijing Hotgen Biotech Company Profile and Main Business
10.5.5 Beijing Hotgen Biotech Recent Developments
10.6 Hangzhou Biotest Biotech CO.,LTD
10.6.1 Hangzhou Biotest Biotech CO.,LTD Company Information, Head Office, Market Area and Industry Position
10.6.2 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.6.3 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Hangzhou Biotest Biotech CO.,LTD Company Profile and Main Business
10.6.5 Hangzhou Biotest Biotech CO.,LTD Recent Developments
10.7 Assure Tech
10.7.1 Assure Tech Company Information, Head Office, Market Area and Industry Position
10.7.2 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.7.3 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Assure Tech Company Profile and Main Business
10.7.5 Assure Tech Recent Developments
10.8 Orient Gene
10.8.1 Orient Gene Company Information, Head Office, Market Area and Industry Position
10.8.2 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.8.3 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Orient Gene Company Profile and Main Business
10.8.5 Orient Gene Recent Developments
10.9 Thermo Fisher
10.9.1 Thermo Fisher Company Information, Head Office, Market Area and Industry Position
10.9.2 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.9.3 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Thermo Fisher Company Profile and Main Business
10.9.5 Thermo Fisher Recent Developments
10.10 Guangzhou Wondfo Biotech Co.,Ltd.
10.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Information, Head Office, Market Area and Industry Position
10.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Company Profile and Main Business
10.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments
10.11 Hangzhou Alltest Biotech Co.,Ltd.
10.11.1 Hangzhou Alltest Biotech Co.,Ltd. Company Information, Head Office, Market Area and Industry Position
10.11.2 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.11.3 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Hangzhou Alltest Biotech Co.,Ltd. Company Profile and Main Business
10.11.5 Hangzhou Alltest Biotech Co.,Ltd. Recent Developments
10.12 Beckman Coulter
10.12.1 Beckman Coulter Company Information, Head Office, Market Area and Industry Position
10.12.2 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.12.3 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Beckman Coulter Company Profile and Main Business
10.12.5 Beckman Coulter Recent Developments
10.13 Bio-Rad
10.13.1 Bio-Rad Company Information, Head Office, Market Area and Industry Position
10.13.2 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.13.3 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Bio-Rad Company Profile and Main Business
10.13.5 Bio-Rad Recent Developments
10.14 BioMerieux
10.14.1 BioMerieux Company Information, Head Office, Market Area and Industry Position
10.14.2 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
10.14.3 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.14.4 BioMerieux Company Profile and Main Business
10.14.5 BioMerieux Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Point-of-care Testing (POCT) for Substance Abuse Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Point-of-care Testing (POCT) for Substance Abuse Market Restraints
Table 3. Point-of-care Testing (POCT) for Substance Abuse Market Trends
Table 4. Point-of-care Testing (POCT) for Substance Abuse Industry Policy
Table 5. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Company, 2019-2024, US$ million
Table 6. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Company, 2019-2024
Table 7. Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share by Company, 2019-2024
Table 9. Global Point-of-care Testing (POCT) for Substance Abuse Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Point-of-care Testing (POCT) for Substance Abuse Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Point-of-care Testing (POCT) for Substance Abuse Mergers & Acquisitions, Expansion Plans
Table 12. Global Point-of-care Testing (POCT) for Substance Abuse Manufacturers Product Type
Table 13. China Point-of-care Testing (POCT) for Substance Abuse Revenue by Company, 2019-2024, US$ million
Table 14. China Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Company, 2019-2024
Table 15. China Point-of-care Testing (POCT) for Substance Abuse Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Point-of-care Testing (POCT) for Substance Abuse Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Point-of-care Testing (POCT) for Substance Abuse Import & Export Trends
Table 19. Main Sources of China Point-of-care Testing (POCT) for Substance Abuse Import
Table 20. Export Destination of China Point-of-care Testing (POCT) for Substance Abuse
Table 21. Global Headquarters and Manufacturing Base of Point-of-care Testing (POCT) for Substance Abuse Manufacturers
Table 22. Global Major Manufacturers, Point-of-care Testing (POCT) for Substance Abuse Capacity Expansion and Future Plans
Table 23. Global Point-of-care Testing (POCT) for Substance Abuse Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Point-of-care Testing (POCT) for Substance Abuse Production by Region, 2019-2024, (K Units)
Table 25. Global Point-of-care Testing (POCT) for Substance Abuse Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Point-of-care Testing (POCT) for Substance Abuse Upstream (Raw Materials)
Table 27. Global Point-of-care Testing (POCT) for Substance Abuse Typical Customers
Table 28. Point-of-care Testing (POCT) for Substance Abuse Typical Distributors
Table 29. By Type, Global Point-of-care Testing (POCT) for Substance Abuse Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Point-of-care Testing (POCT) for Substance Abuse Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Point-of-care Testing (POCT) for Substance Abuse Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Point-of-care Testing (POCT) for Substance Abuse Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Point-of-care Testing (POCT) for Substance Abuse Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Point-of-care Testing (POCT) for Substance Abuse Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share, 2019-2030
Table 37. By Country, Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2019-2030
Table 39. Roche Company Information, Head Office, Market Area and Industry Position
Table 40. Roche Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 41. Roche Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Roche Company Profile and Main Business
Table 43. Roche Recent Developments
Table 44. Danaher Company Information, Head Office, Market Area and Industry Position
Table 45. Danaher Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 46. Danaher Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Danaher Company Profile and Main Business
Table 48. Danaher Recent Developments
Table 49. Abbott Company Information, Head Office, Market Area and Industry Position
Table 50. Abbott Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 51. Abbott Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Abbott Company Profile and Main Business
Table 53. Abbott Recent Developments
Table 54. Siemens Company Information, Head Office, Market Area and Industry Position
Table 55. Siemens Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 56. Siemens Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Siemens Company Profile and Main Business
Table 58. Siemens Recent Developments
Table 59. Beijing Hotgen Biotech Company Information, Head Office, Market Area and Industry Position
Table 60. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 61. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Beijing Hotgen Biotech Company Profile and Main Business
Table 63. Beijing Hotgen Biotech Recent Developments
Table 64. Hangzhou Biotest Biotech CO.,LTD Company Information, Head Office, Market Area and Industry Position
Table 65. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 66. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Hangzhou Biotest Biotech CO.,LTD Company Profile and Main Business
Table 68. Hangzhou Biotest Biotech CO.,LTD Recent Developments
Table 69. Assure Tech Company Information, Head Office, Market Area and Industry Position
Table 70. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 71. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Assure Tech Company Profile and Main Business
Table 73. Assure Tech Recent Developments
Table 74. Orient Gene Company Information, Head Office, Market Area and Industry Position
Table 75. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 76. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Orient Gene Company Profile and Main Business
Table 78. Orient Gene Recent Developments
Table 79. Thermo Fisher Company Information, Head Office, Market Area and Industry Position
Table 80. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 81. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. Thermo Fisher Company Profile and Main Business
Table 83. Thermo Fisher Recent Developments
Table 84. Guangzhou Wondfo Biotech Co.,Ltd. Company Information, Head Office, Market Area and Industry Position
Table 85. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 86. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Guangzhou Wondfo Biotech Co.,Ltd. Company Profile and Main Business
Table 88. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments
Table 89. Hangzhou Alltest Biotech Co.,Ltd. Company Information, Head Office, Market Area and Industry Position
Table 90. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 91. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. Hangzhou Alltest Biotech Co.,Ltd. Company Profile and Main Business
Table 93. Hangzhou Alltest Biotech Co.,Ltd. Recent Developments
Table 94. Beckman Coulter Company Information, Head Office, Market Area and Industry Position
Table 95. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 96. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. Beckman Coulter Company Profile and Main Business
Table 98. Beckman Coulter Recent Developments
Table 99. Bio-Rad Company Information, Head Office, Market Area and Industry Position
Table 100. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 101. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 102. Bio-Rad Company Profile and Main Business
Table 103. Bio-Rad Recent Developments
Table 104. BioMerieux Company Information, Head Office, Market Area and Industry Position
Table 105. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Models, Specifications and Application
Table 106. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 107. BioMerieux Company Profile and Main Business
Table 108. BioMerieux Recent Developments
List of Figure
Figure 1. Point-of-care Testing (POCT) for Substance Abuse Picture
Figure 2. By Revenue, Global Point-of-care Testing (POCT) for Substance Abuse Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Point-of-care Testing (POCT) for Substance Abuse Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Point-of-care Testing (POCT) for Substance Abuse Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Point-of-care Testing (POCT) for Substance Abuse Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Point-of-care Testing (POCT) for Substance Abuse Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Point-of-care Testing (POCT) for Substance Abuse Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Point-of-care Testing (POCT) for Substance Abuse Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Point-of-care Testing (POCT) for Substance Abuse Share of Global Market, 2019-2030
Figure 10. Global Point-of-care Testing (POCT) for Substance Abuse Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 11. Global Point-of-care Testing (POCT) for Substance Abuse Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023
Figure 12. China Point-of-care Testing (POCT) for Substance Abuse Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 13. China Point-of-care Testing (POCT) for Substance Abuse Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 14. China Point-of-care Testing (POCT) for Substance Abuse Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Point-of-care Testing (POCT) for Substance Abuse Domestic VS Export, 2023
Figure 16. Global Point-of-care Testing (POCT) for Substance Abuse Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Point-of-care Testing (POCT) for Substance Abuse Capacity Market Share by Region, 2023 VS 2029
Figure 18. Global Point-of-care Testing (POCT) for Substance Abuse Production Market Share & Forecast by Region, 2019-2030
Figure 19. Point-of-care Testing (POCT) for Substance Abuse Industry Chain
Figure 20. Point-of-care Testing (POCT) for Substance Abuse Procurement Model
Figure 21. Point-of-care Testing (POCT) for Substance Abuse Sales Model
Figure 22. Point-of-care Testing (POCT) for Substance Abuse Sales Channels, Direct Sales and Distribution
Figure 23. Based on Colloidal Gold
Figure 24. Based on Fluorescence Immunochromatography
Figure 25. By Type, Global Point-of-care Testing (POCT) for Substance Abuse Revenue, 2019-2030, US$ Million
Figure 26. By Type, Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share, 2019-2030
Figure 27. By Type, Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030, (K Units)
Figure 28. By Type, Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2019-2030
Figure 29. By Type, Global Point-of-care Testing (POCT) for Substance Abuse Price, 2019-2030, (US$/Unit)
Figure 30. Hospital
Figure 31. Diagnostic Center
Figure 32. Road Traffic Safety
Figure 33. Military
Figure 34. Others
Figure 35. By Application, Global Point-of-care Testing (POCT) for Substance Abuse Revenue, 2019-2030, US$ Million
Figure 36. By Application, Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share, 2019-2030
Figure 37. By Application, Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030, (K Units)
Figure 38. By Application, Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2019-2030
Figure 39. By Application, Global Point-of-care Testing (POCT) for Substance Abuse Price, 2019-2030, (US$/Unit)
Figure 40. By Region, Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share, 2019-2030
Figure 41. By Region, Global Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2019-2030
Figure 42. North America Point-of-care Testing (POCT) for Substance Abuse Revenue & Forecasts, 2019-2030, US$ Million
Figure 43. By Country, North America Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share, 2023
Figure 44. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue & Forecasts, 2019-2030, US$ Million
Figure 45. By Country, Europe Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share, 2023
Figure 46. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Revenue & Forecasts, 2019-2030, US$ Million
Figure 47. By Country/Region, Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share, 2023
Figure 48. South America Point-of-care Testing (POCT) for Substance Abuse Revenue & Forecasts, 2019-2030, US$ Million
Figure 49. By Country, South America Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share, 2023
Figure 50. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Revenue & Forecasts, 2019-2030, US$ Million
Figure 51. U.S. Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030, (K Units)
Figure 52. By Company, U.S. Point-of-care Testing (POCT) for Substance Abuse Market Share, 2023
Figure 53. By Type, U.S. Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 54. By Application, U.S. Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 55. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030, (K Units)
Figure 56. By Company, Europe Point-of-care Testing (POCT) for Substance Abuse Market Share, 2023
Figure 57. By Type, Europe Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 58. By Application, Europe Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 59. China Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030, (K Units)
Figure 60. By Company, China Point-of-care Testing (POCT) for Substance Abuse Market Share, 2023
Figure 61. By Type, China Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 62. By Application, China Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 63. Japan Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030, (K Units)
Figure 64. By Company, Japan Point-of-care Testing (POCT) for Substance Abuse Market Share, 2023
Figure 65. By Type, Japan Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 66. By Application, Japan Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 67. South Korea Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030, (K Units)
Figure 68. By Company, South Korea Point-of-care Testing (POCT) for Substance Abuse Market Share, 2023
Figure 69. By Type, South Korea Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 70. By Application, South Korea Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 71. Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030, (K Units)
Figure 72. By Company, Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Market Share, 2023
Figure 73. By Type, Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 74. By Application, Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 75. India Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030, (K Units)
Figure 76. By Company, India Point-of-care Testing (POCT) for Substance Abuse Market Share, 2023
Figure 77. By Type, India Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 78. By Application, India Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 79. Middle East & Asia Point-of-care Testing (POCT) for Substance Abuse Sales Volume, 2019-2030, (K Units)
Figure 80. By Company, Middle East & Asia Point-of-care Testing (POCT) for Substance Abuse Market Share, 2023
Figure 81. By Type, Middle East & Asia Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 82. By Application, Middle East & Asia Point-of-care Testing (POCT) for Substance Abuse Sales Volume Market Share, 2023 VS 2029
Figure 83. Research Methodology
Figure 84. Breakdown of Primary Interviews
Figure 85. Bottom-up Approaches
Figure 86. Top-down Approaches
Research Methodology:
Point-of-care Testing (POCT) for Substance Abuse Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|